Heloisa Soares, MD, PhD
University of Utah, Division of Oncology
Theranostics

NANETS congratulates Heloisa Soares, MD, PhD of the University of Utah as the NANETS 2020 Theranostics Investigator Scholarship (NTIG) award recipient. The NTIG is intended to push forward the boundaries of molecularly targeted radionuclide therapy and diagnostics for patients with neuroendocrine tumors.

Dr. Soares received the scholarship for her proposal, “The Role of HDAC Inhibitors in Combination to PRRT in NET Xenografts.” Dr. Soares will be mentored by Kathryn Morton, MD, Professor of Radiology at the University of Utah.

NTIG is made possible by the support of Advanced Accelerator Applications (AAA), a long-time supporter of NANETS’ educational events and research. NTIG is a two-year, $100,000 award. The NANETS Scientific Review & Research Committee establishes the award criteria, reviews process, and independently selects the recipient.

Brendan Finnerty, MD
Weill Cornell Medicine
NCIS

NANETS congratulates Brendan Finnerty, MD of Weill Cornell Medicine as the NANETS 2020 Clinical Investigator Scholarship (NCIS) award recipient. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors.  

Dr. Finnerty received the scholarship for his proposal, "Developing a Predictive Molecular Model for Cytologic Detection of Aggressive Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study." Dr. Finnerty will be mentored by Dr. Thomas Fahey, III, Chief of Endocrine and Minimally Invasive Surgery and Professor of Surgery at New York Presbyterian Hospital - Weill Cornell Medicine.

The NCIS grant is a two-year, $100,000 award funded through the generous support of Ipsen Biopharmaceuticals, who has been a funding partner of NANETS since the research grant program’s inception in 2009. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors. The NANETS Scientific Review & Research Committee establishes the award criteria, reviews process, and independently selects the recipient.

Xavier Keutgen, MD
University of Chicago
BTSI 

NANETS congratulates Xavier Keutgen, MD of the University of Chicago Medical Center as the recipient of the 2020 NANETS Basic/Translational Science Investigator (BTSI) for his research, "Deciphering and Potentiating Intrinsic Radiosensitivity of Pancreatic Neuroendocrine Tumors” (PanNETs). Dr. Keutgen will be mentored by Ralph R. Weichselbaum, MD, Chair of the Department of Radiation and Cellular Oncology, University of Chicago, and Co-Director of the Ludwig Center for Metastasis Research, University of Chicago.

The BTSI award is a two-year, $100,000 grant made possible through generous support from the Neuroendocrine Tumor Research Foundation (NETRF). NANETS is grateful to NETRF, whose tremendous investment and support of this annual research grant have made a difference in the NET medical community and the patients we serve. The NANETS Scientific Review & Research Committee establishes the award criteria, reviews process, and independently selects the recipient.